Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiromitsu Ito

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Updates in Surgery|July 11, 2015
The difficulty of laparoscopic liver resectionDaisuke Ban, Atsushi Kudo, Hiromitsu Ito, et al.
Plos One|January 15, 2016
Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and MetastasisHiromitsu Ito, Shinji Tanaka, Yoshimitsu Akiyama, et al.
International Surgery|October 30, 2012
Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a caseTakanori Ochiai, Taiki Masuda, Masayuki Yagi, et al.
Journal of Hepatology|February 28, 2017
ARID2 modulates DNA damage response in human hepatocellular carcinoma cellsAtsushi Oba, Shu Shimada, Yoshimitsu Akiyama, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Updates in Surgery|July 11, 2015
The difficulty of laparoscopic liver resectionDaisuke Ban, Atsushi Kudo, Hiromitsu Ito, et al.
Plos One|January 15, 2016
Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and MetastasisHiromitsu Ito, Shinji Tanaka, Yoshimitsu Akiyama, et al.
International Surgery|October 30, 2012
Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a caseTakanori Ochiai, Taiki Masuda, Masayuki Yagi, et al.
Journal of Hepatology|February 28, 2017
ARID2 modulates DNA damage response in human hepatocellular carcinoma cellsAtsushi Oba, Shu Shimada, Yoshimitsu Akiyama, et al.
Pageof 2